Single Fraction Radiotherapy as Postoperative Treatment (SF-PORT) for Resected, Stage I/II Merkel Cell Carcinoma
Peter H. Goff(University of Washington), Upendra Parvathaneni(University of Washington), Kristina Lachance(University of Washington), Kent E. Wallner(University of Washington), Jay J. Liao(University of Washington), Yolanda D. Tseng(Fred Hutch Cancer Center), E.T. Huynh(University of Washington), Paul Nghiem(Fred Hutch Cancer Center), Matthew A. Cook(University of Virginia), Stephanie K. Schaub(University of Washington), N. Harikrishnan(Dr. M.G.R. Educational and Research Institute), Smith Apisarnthanarax(University of Washington)
International Journal of Radiation Oncology*Biology*Physics
October 25, 2021
Cited by 0
Related Papers
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261
Multivariate statistical analysis of heavy metal concentration in soils of Yelagiri Hills, Tamilnadu, India – Spectroscopical approach
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2014|237
Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
|Journal for ImmunoTherapy of Cancer|2020|197
Human Immunodeficiency Virus Type 1 Vpr-Mediated G<sub>2</sub> Arrest Requires Rad17 and Hus1 and Induces Nuclear BRCA1 and γ-H2AX Focus Formation
|Molecular and Cellular Biology|2004|119